Brief: Creative Medical Technology Holdings Announces Agreement With Greenstone Biosciences Inc For Development Of A Next Generation Ipsc Pipeline For Its Immcelz Immunotherapy Platform
15/06/2022 13:32
June 15 (Reuters) - Creative Medical Technology Holdings Inc
CELZ.O :
* CREATIVE MEDICAL TECHNOLOGY HOLDINGS ANNOUNCES AGREEMENT
WITH
GREENSTONE BIOSCIENCES, INC. FOR DEVELOPMENT OF A NEXT
GENERATION IPSC PIPELINE FOR ITS IMMCELZ® IMMUNOTHERAPY PLATFORM
Source text for Eikon: ID:nPn5bhG1na
Further company coverage: CELZ.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Creative Medical Technology Holdings
See all newsBrief: Creative Medical Technology Buys 4 Million Biodefense Shares For $200,000 Cash And 1 Million Shares On Sept 24
Brief: Creative Medical Technology Holdings Successfully Completes Enrollment And Treatment Across Entire FDA-Cleared Adapt Trial, Including Opioid Cohort, Advancing Celz-201 / Olastrocel Toward Rmat Evaluation And Phase 3 Planning
Creative Medical Technology Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
NASDAQ RESUMED AT 11:07 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:02 AM